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Summary
Background: Opioid users, particularly those with a history of injecting and dependence, have a high risk of fatal poly-
substance and methadone-related overdose. Aim: To describe characteristics of methadone-related overdose deaths and 
assess if differences exist between those dying on and off opioid agonist treatment (OAT). Methods: A descriptive study 
of all persons dying of drug overdose involving methadone on the Irish National Drug Related Deaths Index (NDRDI) 
in 2012 and 2013. Results: A total of 182 methadone-implicated deaths were recorded. 78% (n=142) were male; with a 
mean age of 36 years. Of the cohort, 61% (n=111) were not in receipt of opiate agonist treatment (OAT) at the time of 
death, 15.9% (n=29) had a previous history of non-fatal overdose and 24.7% (n=45) a history of alcohol dependence. 
Analysis and interpretations are limited by incomplete data on other characteristics but where available show that 89% 
(n=73) were injecting drug users, with 57.8% (n=26) injecting drugs at the time of death. History of mental illness was re-
corded in 96.3% (n=77) of cases, with 94.7% (n=107) having history of substance dependency treatment. Polysubstances 
were implicated in 86.8% (n=158) of deaths. The majority died in a private dwelling (74.7% n= 127) and were not alone 
67.4% (n=114). Conclusions: Methadone-related fatal overdose is a significant cause of death in young Irish, who share 
many characteristics with other drug-related deaths. Improved monitoring, risk assessment and OAT retention strategies 
is warranted to inform national drug overdose plans and overdose prevention. 
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1. Introduction
Opioid users, especially those with a serious 
opiate addiction and those who inject drugs, are at 
risk of overdose deaths [4, 11, 18, 22, 25]. Efforts 
to compare accidental drug overdoses across coun-
tries are problematic but there is evidence of increas-
ing deaths from prescription opioids and decreasing 
deaths from illicit drug use [17]. Enhanced and robust 
surveillance and monitoring systems are necessary 
to reduce drug-related deaths among drug users on 
Opioid Agonist Treatment (OAT). With the preva-
lence of methadone-related overdose deaths increas-
ing globally, concerns arise regarding the diversion 
of OAT drugs, in particular black market methadone 
[4, 16]. Recent data in the UK underscored that half 
of drug-related deaths were among people who used 
opiates and had no recent contact with drug services 
[21]. Public Health England commented on various 
contributors to this increased trend in 2016, which 
included variations in the purity and availability of 
street opiates, patterns of poly-substance use, use of 
new psychoactive substances, and the increasing age 
and poor physical health of drug users [24]. 
Whilst OAT, particularly methadone pharma-
cotherapy, is shown to reduce mortality among in-
dividuals with problem opioid use [3, 7, 10, 23, 25, 
26], accidental overdose deaths often occur after a 
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reduction in opioid tolerance following a period of 
abstinence, for example when exiting OAT, recently 
detoxified or prison discharge [6,10, 20, 26]. Cous-
ins et al. [4] observed that primary care methadone 
treatment patients were almost four times more likely 
to die during periods ‘off treatment’, in those initial 
high risk few weeks after leaving treatment. Defini-
tions of ‘off treatment’ generally mean ‘not receiving 
a methadone prescription for three days since the end 
of the previous prescription' [4]. Mortality risks for 
methadone patients include having a history of alco-
hol misuse [13], consuming a methadone dose below 
60mg [15], Human Immunodeficiency Virus (HIV) 
infection [14], medical co-morbidity [19] and history 
of psychiatric illness with co-prescription of benzo-
diazepines [13,19]. Factors reducing overdose risks 
centre on living with a partner, having a younger age, 
not abusing benzodiazepines and remaining in treat-
ment [2, 13, 23]. 
In Ireland (study location), the Irish National 
Drug-Related Deaths Index (NDRDI) report for the 
period 2004-2013 on deaths from poisoning and 
deaths among drug users. The most recent report 
showed that alcohol was implicated in 1 out of 3 
poisoning deaths in 2013, poly-substance poisoning 
in 60% of deaths, and an increase in heroin-related 
deaths [12]. Patterns of benzodiazepine consumption 
and use of other drugs whilst on methadone treatment 
are of increasing concern in Ireland [4, 9]. Irish pa-
tients on methadone identified as having significant 
risk of fatal overdose are those patients with medical 
issues such as HIV and Hepatitis C Virus (HCV) in-
fection, a history of imprisonment and homelessness. 
Another Irish study identified a history of imprison-
ment as being an increased risk of death while on 
methadone treatment [26].
In 1998, the Methadone Treatment Protocol 
(MTP) was introduced in Ireland [8] which resulted 
in a change to how methadone could be prescribed 
and dispensed. These new national regulations re-
quired that all patients being prescribed methadone 
are registered on a central treatment list (CTL). When 
patients are no longer in receipt of methadone through 
either completion of a treatment episode or defaulting 
from treatment, the patient's name is removed from 
the register after one month. It is therefore possible 
to identify which methadone-implicated deaths relate 
to people registered on the CTL and those not regis-
tered. Our study aimed to describe the characteristics 
of methadone-related overdose deaths in Ireland over 
a 24-month period and assess if differences existed 
between those dying when registered and not reg-
istered for OAT. We also considered that there may 
have been identifiable differences between those who 
died and were not on treatment at the time of death 
and those who died and were in receipt of treatment 
at the time of death. 
2. Methods
The National Drug Related Deaths Index (NDR-
DI) in Ireland is an epidemiological database which 
records all deaths by drug and/or alcohol poisoning, 
deaths among drug users and deaths among those who 
are alcohol dependent. To ensure comprehensiveness, 
data for the NDRDI are collected from four sources, 
the Coroner Service, the Hospital In-Patients Enquiry 
Scheme (HIPE), the Central Treatment List (CTL) 
and the General Mortality Register (GMR) through 
the Central Statistics Office. The Coroner Service 
establishes the cause of death in cases of sudden or 
unexpected death and will, following an inquest, 
determine the cause of violent or unnatural deaths 
including those caused by drug and alcohol poison-
ing. Data from 48 coroners districts nationally are 
included in the NDRDI. HIPE is a computer-based 
patient information system which collects medical 
data on discharges and deaths in acute general hospi-
tals in Ireland. Sixty hospitals, accounting for 95% of 
all hospitals nationally, enter data on this register and 
where appropriate this data is automatically entered 
onto the NDRDI. The CTL is a statutory register of 
all patients receiving methadone treatment in Ireland. 
This register provides data for those on methadone 
treatment at the time of death which is sent electroni-
cally to the NDRDI by CTL staff. The GMR formally 
records, categorises and codes all notified deaths in 
Ireland with only one underlying cause and one exter-
nal cause recorded for each death. This data are sent 
electronically to the NDRDI. Cases from the different 
data sources are cross-matched to avoid duplication 
and a comprehensive set of variables is collected on 
each unique drug-related death. 
The NDRDI categorises drug-related deaths into 
poisonings and non-poisonings. Poisonings or fatal 
overdoses are defined as deaths in individuals due to 
the toxic effects of the consumption of drug(s) and/
or other substance(s) and do not include adverse re-
actions to prescribed medications. For this study, all 
methadone-related poisoning deaths were extracted 
from the NDRDI for 2012 and 2013. Anonymised 
data on the following characteristics was collected on 
the full study cohort (n = 182); age, gender, place of 
residence, registered for methadone treatment, drug 
- 7 -
M.C. Van Hout et al.: Characteristics of methadone-related overdose deaths and comparisons between those dying on and off opioid agonist 
treatment (OAT):  A national cohort study.
and alcohol dependence, history of overdose, history 
of blood borne viruses, ante- and post-mortem toxi-
cology. Incomplete data was available on the follow-
ing characteristics, location at time of death (n=170), 
presence of others at fatal overdose (n=169), history 
of mental illness (n=80), history of injecting (n=82), 
ever treated for substance dependency (n=113), in-
jecting at time of death (n=45) and treated for drug 
problems at the time of death. (n=97). Descriptive 
statistics (frequencies, percentages) were used to 
summarise the characteristics of those dying of meth-
adone-related poisonings. Statistical tests using SPSS 
included chi-squared tests, t-tests and p-values were 
used to assess differences in categorical data, with a 
significance level of 0.05. Multi-nominal logistic re-
gression analysis was used to determine predictors 
for being on and off methadone treatment at the time 
of death. 
3. Results
There were 182 poisoning deaths where meth-
adone was implicated as a cause of death on the 
NDRDI over the two-year period 2012-2013. Of the 
182 individuals included, over three quarters (78%, 
n=142) were male; the mean age was 36 years with 
the lower and upper quartiles being 28.75 and 41 
years, and 70.3% of the deceased were resident in 
Dublin city or county. The place of death was record-
ed for 170 of the cases with the majority (74.7%, n= 
127) dying in a private residence, 12.6% (n=23) in a 
homeless hostel, and 7.6% (n=14) dying in either a 
public place or building. Where recorded (n=169), in 
over two thirds (67.5%) of fatal overdoses there was a 
third-party present (Table 1).
The majority of the deceased were not registered 
for OAT at the time of death, 61% (n=111). One quar-
ter 24.7% (n=45) of the individuals who died were 
known to have alcohol dependency and 15.9% (n=29) 
had a history of overdose in the past. Where recorded, 
the most common blood borne virus (BBV) infection 
in this cohort was HCV (23.6%), followed by HIV 
(6.6%) and Hepatitis B Virus (HBV)(1.6%). However 
history of BBV was not always available in the sourc-
es used by the NDRDI. For several characteristics, 
data was not available to the NDDRI from the avail-
able sources. For clarity, the denominators for these 
characteristics are included in brackets. Where data 
was available, 96.3% (77/80) had a known history of 
mental illness, 89% (73/82) of individuals were re-
Table 1: Demographics
n %
Year
2012 89 49.9
2013 93 51.1
Sex
Male 142 78.0
Female 40 22.0
Age Group
<25 24 13.2
25-34 74 40.6
35-44 47 39.1
45+ 37 20.3
Place of residence
Dublin city/county 128 70.3
Other city area 12 6.6
Other areas 42 23.1
Location of death
Private dwelling 127 74.7
Homeless accommodation 23 12.6
Public place 9 4.9
Public building 5 2.7
Other 6 3.3
Present at time of death
Alone 55 32.5
Partner/children 27 16.0
Family 37 21.9
Friends 24 14.2
Other 26 15.4
Known to be registered on OAT at 
time of death 71 39.0
 
Table 2: Dependencies and Treatment History
n %
A. Mental Illness
A1. Alcohol dependency men-
tioned 45(/182) 24.7
A2. History of mental illness 77 (/80) 96.3
A3. Ever treated for substance 
dependency 107 (/113) 94.7
B. Drug Use
B1. Recorded history of overdose 29 (/182) 15.9
B2. History of injecting drugs 73 (/82) 89.0
B3. Injecting at time of death 26 (/45) 57.8
B4. Treated for drug problem at 
time of death 89 (/97) 91.8
C. Virology recorded
C1. Hepatitis B 4 (/182) 2.2
C2. Hepatitis C 43 (/182) 23.6
C3. Hepatitis Unspecified 3 (/182) 1.6
C4. HIV 12 (/182) 6.6
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corded as having a history of injecting drugs, with 
57.8% (26/45) documented as injecting drugs at the 
time of their death. The majority, 94.7% (107/113), 
had been treated for substance dependency at some 
stage, with 91.8% (89/97) being treated for problem 
drug use at the time of death (Table 2).
Table 3 compares those registered for OAT at the 
time of death to those who were registered for OAT. 
When comparing the available data for those who 
were registered for OAT at their time of death, sta-
tistically significant differences were found in: mean 
age (p=0.003), place of residency (p=0.024), ever 
treated for drug dependency (p=0.000) and Hepatitis 
C (p=0.003); however, none of these remained sig-
nificant on the multivariate logistic regression, except 
those who had been recorded as ever treated for drug 
dependency.
Ante- and/or post-mortem toxicology results 
were available for 171 of cases, with the majority, 
86.8% (n=158), of the deaths being poly-substance 
related (including opiates, such as heroin and metha-
done). Methadone alone was found in 9% (n=16) of 
cases and 3.5% (n=6) were found to have opiates 
alone. A wide range of drugs were found in the toxi-
cology results. Significant differences were noted re-
garding those registered and non-registered CTL indi-
viduals in terms of their use of prescribed medication. 
Individuals not registered on the CTL were statisti-
cally more likely to be using non-prescribed metha-
done (p<0.01), diazepam (p=0.02) and mirtazapine 
(p=0.02) at the time of death. (Table 4). 
4. Discussion
This study reports on a particular cohort of drug-
related deaths in Ireland where methadone has been 
implicated in the death, and builds on earlier studies 
conducted using NDRDI data [12]. There is growing 
concern about drug-related deaths in many jurisdic-
tions [1, 6, 17]. The role that prescribed and diverted 
methadone plays in these deaths has been documented 
[4, 16] but there is a paucity of research on this unique 
cohort [13]. The study examined in greater detail the 
characteristics of those who died where methadone 
was implicated in the cause of death and to examine 
if there were differences in the characteristics of pa-
tients who were registered for OAT and those who 
were not. 
Table 3 Comparison between those on OAT and not on OAT
Not registered on OAT 
at the time of death 
(n=111)
Registered on OAT 
at the time of death (n=71) p-value
Mean age 34.22 (SD: 11.0) 38.99 (SD: 8.4) *0.003
Sex
Male
Female
74.6 (89/111)
25.4 (22/111)
80.2 (53/71)
19.8 (18/71)
0.463
Place of residence
Dublin city/county
Other city area
Other areas
63.1 (70/111)
6.3 (7/111)
30.6 (34/111)
81.6 (58/71)
7.0 (5/71)
11.4 (8/71)
*0.024
Alcohol dependency mentioned 27.0 (30/111) 21.1 0.386
Ever Treated for drug dependency 73.1 (19/26) 98.6 *<0.01
Ever Injected 79.5 (31/39) 97.7 *0.012
Injecting at time of death 55.0 (11/20) 60.0 0.220
History of mental illness 97.7 (43/44) 94.4 0.585
Ever treated for substance dependency 85.7 (36/42) 100 *0.002
Hepatitis C 16.2 (18/111) 35.2 *0.004
HIV 4.5 (5/111) 9.9 0.220
Polydrug poisoning 91.9 102/111) 87.3 0.322
Coroner’s verdict (n=171) 0.148
Accident 1.0 (1/104) 0 (0/67)
Misadventure 77.9 (81/104) 89.6 (60/67)
Suicide 4.8 (5/104) 1.5 (1/67)
No verdict/Not recorded 16.3 (17/104) 8.9 (6/67)
Continuous variables assessed by independent T-test; Categorical variables assessed by Chi-square. *Variables deemed 
statistically significant, p<0.05
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This study shows that methadone-related deaths 
account for a significant number of deaths in young 
men in Ireland. Over a two-year period, 142 men with 
a mean age of 36 years died in Ireland from what is 
a preventable cause of death. Despite the numbers, 
these deaths do not get the same attention, for exam-
ple as road traffic deaths or deaths by suicide. Of note 
is the number of very young people (< 25 years) (n= 
24) in this cohort. With an aging opiate using popula-
tion, this finding was unexpected. Comparative analy-
sis between those on and off treatment showed those 
dying off treatment were younger than those on treat-
ment. Being on OAT may account for this finding, but 
consideration should also be given to the possibility 
that this group contains a younger cohort of less ex-
perienced drug users who had not yet come in contact 
with OAT. Further analysis of this younger cohort is 
necessary to determine their unique characteristics 
and inform specific overdose prevention to target this 
group.
This study showed that more people died off 
treatment (not registered for OAT) than in treatment 
(registered for OAT). Another Irish study which found 
that patients treated with methadone were nearly four 
times more likely to die in periods off treatment [4]. Of 
note is the numbers of those ever treated for substance 
dependence (94.7%). Accessing treatment offers an 
opportunity to target overdose strategies to this at-risk 
group. Consideration should be given to expanding 
opioid overdose strategies to services providing treat-
ment for all drug types. This strategy is further sup-
ported by the study’s finding that the majority of fatal 
methadone-related overdoses were poly-substance 
in nature, as evidenced in the literature [4, 9, 12,13, 
24]. Some of those who died where methadone was 
implicated may not be opioid dependant and the use 
of diverted methadone may be experimental or used 
for the purpose of self-medicating for example with-
drawal symptoms from other drugs. While significant 
numbers of those who died had previous contact with 
drug treatment services, the data available did not in-
dicate if these were OAT providers.
Retaining patients in OAT is an essential compo-
nent of any national overdose prevention strategy [1, 
6, 23]. This includes easy access, in a timely fashion, 
to OAT which should include the option of buprenor-
phine. OAT in Ireland [8] has expanded hugely over 
the past two decades with numbers in treatment ex-
panding to over ten thousand. This accounts for ap-
proximately 50% of identified opioid users. Despite 
this high coverage there are still significant waiting 
times for OAT in some parts of the country with very 
limited access to buprenorphine as an alternative op-
tion to methadone. There is also concern that the OAT 
delivery models are preventing some opioid depend-
ant patients, in particular those with over the counter 
(OTC) and prescribed opioid dependence accessing 
appropriate services [27]. Cousins et al. [4] reported 
that whilst numbers on methadone treatment are on 
the increase in Ireland, with a third treated in primary 
care, no corresponding decrease in deaths from opioid 
overdose has been recorded. This may, in part, be due 
to the above identified issues but also methadone di-
version may be a contributing factor. The benefits and 
Table 4 – Toxicology Results
Substance N % On OAT
% Not on 
OAT
% OAT not pre-
scribed
% Non OAT 
not prescribed p-value
Methadone 171 40.9 59.1 34.3 91.1 *<0.01
Heroin 60 46.7 53.3 100.0 100.0 -
Hypnotics (Non 
BZO) 84 44.0 56.0 78.4 87.2 0.378
Diazepam 131 39.7 60.3 71.2 87.3 *0.025
Alcohol 61 34.4 65.6 100.0 100.0 -
Flurazepam 52 55.8 44.2 69.0 91.3 0.086
Alprazolam 31 48.4 51.6 93.3 100.0 0.484
Amitryptlline 16 81.3 18.8 61.5 100.0 0.509
Cocaine 21 33.3 66.7 100.0 100.0 -
Mirtazapine 54 46.3 53.7 64.0 89.7 *0.046
Olanzapine 23 60.9 39.1 57.1 55.6 1.00
Tramadol 15 33.3 66.7 80.0 70.0 1.00
Citalopram 14 35.7 64.3 100.0 66.7 0.258
Continuous variables assessed by independent T-test; Categorical variables assessed by Chi-square. *Variables deemed 
statistically significant, p<0.05.
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protection afforded by OAT may be eroded by metha-
done diversion [4,16]. Further research is needed to 
establish the extent to which diversion contributes to 
methadone-related deaths in Ireland. Supervision of 
methadone, known to reduce overdose, is intrinsic to 
OAT in Ireland [8]. National OAT guidelines recom-
mend full supervision in the first three months during 
the induction and stabilisation phases and thereafter 
reduced with increasing stability. The guidelines also 
recommend at least one methadone dose to be super-
vised weekly with doses of 80mls or more supervised 
at least twice weekly. Despite these guidelines, most 
methadone-related deaths in Ireland appear to be due 
to diverted methadone. 
A third of methadone-related deaths are in pa-
tients accessing OAT. These patients are in contact 
with services, which provides a unique opportunity to 
risk assess and engage them in overdose prevention 
interventions such as overdose recognition, Cardio 
Pulmonary Resuscitation (CPR) and naloxone ad-
ministration training. This study found that the ma-
jority of patients were not alone and were in a private 
dwelling at the time of the fatal overdose which sup-
ports the involvement of peers and family in overdose 
prevention programs. Of note was the low numbers of 
fatal overdoses occurring in homeless centres. Given 
that homelessness significantly increases mortality 
among opioid users and the high level of homeless-
ness experienced by drug users in Ireland, this find-
ing was contrary to what might be expected. It may 
be explained in part by the fact that OAT homeless 
accommodation in Ireland are staffed by experienced 
and well trained staff knowledgeable on the signs and 
treatment of overdose and the multi-occupancy of the 
sleeping accommodation where overdoses might be 
witnessed by third parties. 
This national study is unique in an Irish context 
and is one of only a few studies that looks specifically 
at methadone-related deaths, and includes all patients 
dying over a two-year period in Ireland. Given the use 
of four different data sources by the NDRDI is it very 
unlikely that methadone-related deaths were missed 
or that duplications occurred. The missing data was 
due to it not being present in the original data sources 
used to populate the NDRDI. The number of different 
variables included in the data set are ambitious and 
if all data was available would provide a unique in-
sight into this cohort. Consideration should be given 
to expanding data sources for the register, including 
the use of a standardised template that could be com-
pleted by the treatment provider at the time of death 
or last treatment provider known.
A number of limitations were identified in this 
study. Data was incomplete for many of the character-
istics because it was not always available in the data 
sources that the NDRDI have access to. This makes 
analysis and interpretations difficult. The researchers, 
where possible, have identified the real denominator 
in the tables to clarify findings. The research is also 
limited by not being able to differentiate the different 
groups represented by those not registered for OAT. 
This includes: those never treated, just completed 
treatment, on waiting lists for OAT or in receipt of 
buprenorphine. There are also limitations in the inter-
pretation of the “on CTL” group. These may include 
patients who have ceased OAT in the past 28 days but 
have not yet been exited from the register as patients 
remain on the treatment register for one month post 
treatment completion or default from treatment. This 
group is considered a high-risk group for overdose [4, 
6,10, 20, 26] and has the potential to underestimate 
the numbers dying off treatment.
5. Conclusions
 Methadone-related fatal overdose is a signifi-
cant cause of death in young men in Ireland. This 
unique population share many of the same charac-
teristics as other drug-related deaths [4, 11, 13, 18, 
19, 22, 24, 25]. These are male gender, age (mid to 
late thirties), previous history of contact with treat-
ment services, history of injecting drugs, high levels 
of mental illness, polysubstance toxicology on post-
mortem and not in receipt of OAT. The majority dying 
from methadone-related overdose were not alone at 
the time of death and died in a private dwelling. The 
majority of patients were not on OAT at the time of 
the overdose but had previous contact with drug treat-
ment services. These factors combined with other 
identified patient characteristics along with improved 
risk assessment and OAT retention strategies should 
inform any Irish national drug overdose plan. Improv-
ing access to more data sources for the NDRDI would 
provide more comprehensive data and further assist 
with targeting overdose prevention strategies. 
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